Pazokast 400 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Pazokast 400 mg Tablet contains pazopanib, a tyrosine kinase inhibitor. Its labelling describes it for the treatment of kidney cancer and soft tissue sarcoma. It is described as binding and inhibiting the enzyme receptors responsible for the proliferation of cancer cells, and as restricting the growth of new blood vessels within the tumour. It is taken at the same time every day and can be taken on an empty stomach; the directions may change with the condition, an overdose should be avoided, and the benefits may take weeks or months to show.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of kidney cancer
- Described for the treatment of soft tissue sarcoma
- Also listed for pancreatic cancer, small cell and non-small cell lung cancer, liver cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of the colon and rectum, chronic idiopathic myelofibrosis, and breast cancer
- Described as inhibiting the enzyme receptors that drive cancer-cell proliferation and restricting tumour blood-vessel growth
Described Dosage & Administration
- Swallowed whole; not chewed, broken, or crushed
- Taken on an empty stomach at the same time every day, following the doctor’s instructions
- The directions may change with the condition; an overdose should be avoided at all costs
- Benefits may take weeks or even months to show visible changes
Described Side Effects
Commonly described side effects include:
- Headache
- Nausea and vomiting
- Bone, muscle, or joint pain
- Fatigue
- Change in the colour of hair
- Diarrhoea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Breathlessness
These are described as commonly temporary. The doctor should be consulted if any of them are persistent.
Precautions
- An updated medical history should be shared with the doctor
- The doctor should be informed of heart disease, liver or kidney issues, or any medicines being taken for infections
- Described as not for pregnant or breastfeeding women
- Effective contraceptives should be used to avoid pregnancy
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains pazopanib and is used for the treatment of kidney cancer and soft tissue sarcoma. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole on an empty stomach at the same time every day, without chewing, breaking, or crushing, following the doctor’s instructions.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.